Ascendis Pharma A/S (ASND)

Ascendis Pharma Stock Forecast

Stock Price Forecast

The 8 analysts with 12-month price forecasts for Ascendis Pharma stock have an average target of 170.25, with a low estimate of 89 and a high estimate of 260. The average target predicts an increase of 18.91% from the current stock price of 143.18.

Analyst Consensus: Buy

Target	Low	Average	Median	High
Price	$89	$170.25	$173	$260
Change	-37.84%	+18.91%	+20.83%	+81.59%

Analyst Ratings

The average analyst rating for ASND stock from 8 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Rating	Nov '23	Dec '23	Jan '24	Feb '24	Mar '24	Apr '24
Strong Buy	2	3	3	3	3	2
Buy	4	4	4	3	3	4
Hold	3	3	3	3	3	2
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	9	10	10	9	9	8

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Vikram Purohit Morgan Stanley	Morgan Stanley	Hold Maintains $116	Hold	Maintains	$116	-18.98%	Apr 22, 2024
Li Watsek Cantor Fitzgerald	Cantor Fitzgerald	Buy Reiterates $173	Buy	Reiterates	$173	+20.83%	Apr 18, 2024
Jessica Fye JP Morgan	JP Morgan	Buy Maintains $165 → $167	Buy	Maintains	$165 → $167	+16.64%	Apr 2, 2024
Li Watsek Cantor Fitzgerald	Cantor Fitzgerald	Buy Reiterates $173	Buy	Reiterates	$173	+20.83%	Apr 1, 2024
Derek Archila Wells Fargo	Wells Fargo	Buy Maintains $196 → $260	Buy	Maintains	$196 → $260	+81.59%	Mar 15, 2024

More Analyst Ratings

Financial Forecast

Revenue This Year

440.73M

Increased by 65.24%

from 266.72M

Revenue Next Year

752.51M

Increased by 70.74%

from 440.73M

EPS This Year

-4.60

from -8.55

EPS Next Year

-0.37

from -4.60

Year	2019	2020	2021	2022	2023	2024	2025	2026	2027	2028
Revenue	13.38M	6.95M	7.78M	51.17M	266.72M	440.73M	752.51M	1.22B	1.77B	2.34B
Revenue Growth	26.41%	-48.01%	11.87%	557.93%	421.20%	65.24%	70.74%	61.59%	45.72%	32.22%
EPS	-4.69	-8.28	-7.00	-10.40	-8.55	-4.60	-0.37	3.92	12.87	18.90
EPS Growth	-	-	-	-	-	-	-	-	228.64%	46.84%
No. Analysts	-	-	-	-	-	15	15	12	7	7

Financial currency is EUR. Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2024	2025	2026	2027	2028
High	516.0M	1.0B	1.9B	2.3B	3.6B
Avg	440.7M	752.5M	1.2B	1.8B	2.3B
Low	373.4M	616.0M	869.6M	1.1B	1.3B

Revenue Growth

Revenue Growth	2024	2025	2026	2027	2028
High	93.5%	127.4%	158.7%	90.7%	104.8%
Avg	65.2%	70.7%	61.6%	45.7%	32.2%
Low	40.0%	39.8%	15.6%	-9.1%	-23.9%

EPS Forecast

EPS	2024	2025	2026	2027	2028
High	-2.67	4.49	9.07	20.87	37.33
Avg	-4.60	-0.37	3.92	12.87	18.90
Low	-6.44	-2.90	0.60	4.80	7.36

EPS Growth

EPS Growth	2024	2025	2026	2027	2028
High	-	-	-	432.7%	190.0%
Avg	-	-	-	228.6%	46.8%
Low	-	-	-	22.5%	-42.8%

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.